On December 13 at 1 p.m. EST, RealClearPolitics will host a virtual event, “The Consequences of Targeting Pharmacy Benefits.” The event will bring together policymaker and expert voices to explore the potential negative impact of policies being considered by Congress that target pharmacy benefit companies and market-based incentives in the pharmacy market.

The event includes opening Q&A sessions from former U.S. Senator Pat Toomey (R-PA) and U.S. Representative Eric Burlison (R-MO-07), and a robust panel of experts. Panelists include Alex Brill, founder and CEO of Matrix Global Advisors (MGA), Ike Brannon, president of Capital Policy Analytics, and Maura Keefe, spokeswoman for the Coalition for Affordable Prescription Drugs (CAPD). The event will be moderated by co-founder and president of RealClearPolitics, Tom Bevan.

When: Wednesday, December 13 at 1 p.m. EST

What: A health care briefing to bring together policymaker and expert voices to explore the

potential negative impact of policies being considered by Congress that target pharmacy benefit companies and market-based incentives in the pharmacy market

Where: Virtual, Register HERE

Who: Anyone interested in learning about the drug pricing debate in Congress

Register for the event HERE.

###

PCMA is the national association representing America’s pharmacy benefit companies. Pharmacy benefit companies are working every day to secure savings, enable better health outcomes, and support access to quality prescription drug coverage for more than 275 million patients. Learn more at www.pcmanet.org